New & Upcoming Projects in Hospitality and Healthcare Projects in Telangana – Page 19
154 upcoming and ongoing hospitality and healthcare projects in Telangana worth ?0.32 lakh crore, with investment, location, project stage and latest status. Last updated 17 Sep 2026.
Projects tracked
154
Total investment
₹0.32 lakh crore
Projects above ₹100 Cr
49
Added in the last 30 days
0
Latest hospitality and healthcare projects in Telangana
Showing 91–95 of 154
Project Work CommencedMedical Devices & BiologicsUpdated
A dental filling material manufacturing project in Telangana's Medical Devices Park approved, with a capacity of 300,000 units/month. Cost: Rs. 132.9M. State pollution authorities granted consent in Feb '24, ensuring environmental compliance.
A medical college in Vangapahad, Hasanparthy, Hanumakonda, Telangana, covering 31,753 sqm. The project, estimated at Rs. 350 million, has received consent from state pollution control authorities for establishment as of January 2024.
A company is planning to set up a greenfield animal vaccine manufacturing facility in Genome Valley, Hyderabad, Telangana, to make Foot and Mouth disease and other emerging diseases. The estimated cost of the project is Rs. 7000 million and as of October 2022, pre-project activities are underway.
A pharmaceutical company plans to expand its R&D unit in Uppal, Nacharam, Telangana, with a project cost of Rs.1827.4 million. Having secured consent from pollution control authorities in January 2022, the expansion aims to drive local economic growth, generate employment, and contribute to Telangana's flourishing pharmaceutical sector. The state government's support and industry-focused initiatives make Telangana an appealing hub for pharmaceutical companies. As of January 2024, the R&D unit expansion involves an investment of Rs.2571.069 million, with approved consent from pollution control authorities.
A new Rs. 111.573 million Research and Development unit in biotechnology is underway in Telangana's IDA Nacharam. The multifaceted project, encompassing contract research, pharmacogenomics, diagnostics, and bioinformatics, has obtained consent from state pollution control authorities as of December 2023. This strategic initiative aligns with regional biotech advancements, showcasing a commitment to innovation and scientific progress.